Literature DB >> 28303304

Precision diabetes: a realistic outlook on a promising approach.

Sally M Marshall1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28303304     DOI： 10.1007/s00125-017-4244-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  8 in total

1.  DR. KARL LANDSTEINER NOBEL PRIZE LAUREATE IN MEDICINE, 1930.

Authors:  S Bayne-Jones
Journal:  Science       Date:  1931-06-05       Impact factor: 47.728

2.  Mild familial diabetes with dominant inheritance.

Authors:  R B Tattersall
Journal:  Q J Med       Date:  1974-04

Review 3.  Vemurafenib: the first drug approved for BRAF-mutant cancer.

Authors:  Gideon Bollag; James Tsai; Jiazhong Zhang; Chao Zhang; Prabha Ibrahim; Keith Nolop; Peter Hirth
Journal:  Nat Rev Drug Discov       Date:  2012-10-12       Impact factor: 84.694

Review 4.  Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?

Authors:  Jose C Florez
Journal:  Diabetologia       Date:  2017-03-10       Impact factor: 10.122

Review 5.  Precision diabetes: learning from monogenic diabetes.

Authors:  Andrew T Hattersley; Kashyap A Patel
Journal:  Diabetologia       Date:  2017-03-17       Impact factor: 10.122

Review 6.  Genetics of obesity: can an old dog teach us new tricks?

Authors:  Giles S H Yeo
Journal:  Diabetologia       Date:  2016-12-24       Impact factor: 10.122

Review 7.  Lifestyle and precision diabetes medicine: will genomics help optimise the prediction, prevention and treatment of type 2 diabetes through lifestyle therapy?

Authors:  Paul W Franks; Alaitz Poveda
Journal:  Diabetologia       Date:  2017-01-25       Impact factor: 10.122

Review 8.  Painting a new picture of personalised medicine for diabetes.

Authors:  Mark I McCarthy
Journal:  Diabetologia       Date:  2017-02-07       Impact factor: 10.122
  8 in total
  4 in total

1.  Integration of Infant Metabolite, Genetic, and Islet Autoimmunity Signatures to Predict Type 1 Diabetes by Age 6 Years.

Authors:  Bobbie-Jo M Webb-Robertson; Ernesto S Nakayasu; Brigitte I Frohnert; Lisa M Bramer; Sarah M Akers; Jill M Norris; Kendra Vehik; Anette-G Ziegler; Thomas O Metz; Stephen S Rich; Marian J Rewers
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

2.  Diabetes affects endothelial cell function and alters fibrin clot formation in a microvascular flow model: A pilot study.

Authors:  Lorenz Jenny; Andreas Melmer; Markus Laimer; Elaissa T Hardy; Wilbur A Lam; Verena Schroeder
Journal:  Diab Vasc Dis Res       Date:  2020 Jan-Feb       Impact factor: 3.291

3.  Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy.

Authors:  John M Dennis; Beverley M Shields; Anita V Hill; Bridget A Knight; Timothy J McDonald; Lauren R Rodgers; Michael N Weedon; William E Henley; Naveed Sattar; Rury R Holman; Ewan R Pearson; Andrew T Hattersley; Angus G Jones
Journal:  Diabetes Care       Date:  2018-01-31       Impact factor: 19.112

4.  Prediction of the development of islet autoantibodies through integration of environmental, genetic, and metabolic markers.

Authors:  Bobbie-Jo M Webb-Robertson; Lisa M Bramer; Bryan A Stanfill; Sarah M Reehl; Ernesto S Nakayasu; Thomas O Metz; Brigitte I Frohnert; Jill M Norris; Randi K Johnson; Stephen S Rich; Marian J Rewers
Journal:  J Diabetes       Date:  2020-08-16       Impact factor: 4.006
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.